Cargando…
Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma
PURPOSE: To construct a multi-institutional radiomic model that supports upfront prediction of progression-free survival (PFS) and recurrence pattern (RP) in patients diagnosed with glioblastoma multiforme (GBM) at the time of initial diagnosis. PATIENTS AND METHODS: We retrospectively identified da...
Autores principales: | Fathi Kazerooni, Anahita, Akbari, Hamed, Shukla, Gaurav, Badve, Chaitra, Rudie, Jeffrey D., Sako, Chiharu, Rathore, Saima, Bakas, Spyridon, Pati, Sarthak, Singh, Ashish, Bergman, Mark, Ha, Sung Min, Kontos, Despina, Nasrallah, MacLean, Bagley, Stephen J., Lustig, Robert A., O’Rourke, Donald M., Sloan, Andrew E., Barnholtz-Sloan, Jill S., Mohan, Suyash, Bilello, Michel, Davatzikos, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113126/ https://www.ncbi.nlm.nih.gov/pubmed/32191542 http://dx.doi.org/10.1200/CCI.19.00121 |
Ejemplares similares
-
Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)
por: Rathore, Saima, et al.
Publicado: (2021) -
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
por: Bakas, Spyridon, et al.
Publicado: (2022) -
Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021) -
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2022) -
MRI image analysis methods and applications: an algorithmic perspective using brain tumors as an exemplar
por: Vadmal, Vachan, et al.
Publicado: (2020)